Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
π Abstract
Abstract: Mechanistic, multicellular, agent-based models are commonly used to
investigate tissue, organ, and organism-scale biology at single-cell
resolution. The Cellular-Potts Model (CPM) is a powerful and popular framework
for developing and interrogating these models. CPMs become computationally
expensive at large space- and time- scales making application and investigation
of developed models difficult. Surrogate models may allow for the accelerated
evaluation of CPMs of complex biological systems. However, the stochastic
nature of these models means each set of parameters may give rise to different
model configurations, complicating surrogate model development. In this work,
we leverage denoising diffusion probabilistic models to train a generative AI
surrogate of a CPM used to investigate in vitro vasculogenesis. We describe the
use of an image classifier to learn the characteristics that define unique
areas of a 2-dimensional parameter space. We then apply this classifier to aid
in surrogate model selection and verification. Our CPM model surrogate
generates model configurations 20,000 timesteps ahead of a reference
configuration and demonstrates approximately a 22x reduction in computational
time as compared to native code execution. Our work represents a step towards
the implementation of DDPMs to develop digital twins of stochastic biological
systems.
Authors (6)
Tien Comlekoglu
J. Quetzalcoatl Toledo-MarΓn
Douglas W. DeSimone
Shayn M. Peirce
Geoffrey Fox
James A. Glazier
Key Contributions
Leverages denoising diffusion probabilistic models (DDPMs) to train a generative AI surrogate for a computationally expensive mechanistic agent-based model (Cellular-Potts Model) used in studying in vitro vasculogenesis. It uses an image classifier to characterize unique areas of the parameter space, facilitating surrogate development for stochastic models.
Business Value
Speeds up biological research by allowing faster simulation and exploration of complex biological processes, potentially accelerating drug discovery and understanding of diseases.